default author photo

Wenjuan Jiang

Central South University - Department of Medical Oncology

China

SCHOLARLY PAPERS

3

DOWNLOADS

140

TOTAL CITATIONS

5

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Landscape of Next Generation Sequencing in Screening Accurate Benefit Population for First Line Crizotinib in ALK Rearranged Advanced Non-Small Cell Lung Cancer

Number of pages: 21 Posted: 24 Jan 2019
Liang Zeng, Chunhua Zhou, Yizhi Li, Lin Wu, Chen Xia, Wenjuan Jiang, Yijuan Hu, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Yi Xiong, Rui Guan, Yongchang Zhang and Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Second Chest Cancer Unit, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 56 (1,000,027)
Citation 4

Abstract:

Loading...

NGS, Ventana, ALK, Fusion partners, Crizotinib

2.

Apatinib Plus Vinorelbine in Second Line Treatment Failure Wildtype Advanced Non-Small Cell Lung Cancer (VICTOR): A Phase II Three-Dimensional Co-Culture Platforms-Guided Prospective Study

Number of pages: 33 Posted: 24 Sep 2019
Xiangyu Zhang, Yi Xiong, Qing Xia, Fang Wu, Lingli Liu, Yuling Zhou, Liang Zeng, Chunhua Zhou, Chen Xia, Wenjuan Jiang, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Rui Guan, Kunyan Li, Jing Wang, Lei Guang, Yongchang Zhang and Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Hepatology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 46 (1,109,210)
Citation 1

Abstract:

Loading...

Three-Dimensional Co-Culture, Apatinib, Vinorelbine, Second Line Treatment Failure, Non-small Cell Lung Cancer, Prospective Study

3.

Apatinib Combined with Vinorelbine in Second Line Treatment Failure Non-Driver Mutation Advanced Non-Small Cell Lung Cancer(VICTOR): A Phase 2, Single-Arm, Prospective Study

Number of pages: 24 Posted: 22 May 2019
Xiangyu Zhang, Yi Xiong, Qing Xia, Fang Wu, Lingli Liu, Yuling Zhou, Liang Zeng, Chunhua Zhou, Chen Xia, Wenjuan Jiang, Dehua Liao, Lili Xiao, Li Liu, Haiyan Yang, Rui Guan, Kunyan Li, Jing Wang, Lei Guang, Yongchang Zhang and Nong Yang
Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Shanghai Jiao Tong University (SJTU) - Department of Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Hepatology, Central South University - Department of Medical Oncology, Central South University - Department of Pharmacy, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Department of Medical Oncology, Central South University - Hunan Cancer Hospital, Central South University - Hunan Cancer Hospital, The University of Texas MD Anderson Cancer Center - Department of Experimental Radiation Oncology, Central South University - Department of Medical Oncology and Central South University - Department of Medical Oncology
Downloads 38 (1,209,354)

Abstract:

Loading...

Apatinib, Vinorelbine, Second Line Treatment Failure, Non-small Cell Lung Cancer, Prospective Study